Sun, Jun 03, 2018
Merck’s pharma segment’s revenue grew 14%YoY to Rs 2.24 billion in C4FY17 from Rs1.96 billion due to re-stocking by trade post successful GST implementation.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.